Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Alzchem Group stock

ACT.DE
DE000A2YNT30
A2YNT3

Price

56.60
Today +/-
-0.60
Today %
-1.05 %

Alzchem Group stock price

%
Weekly
Details

Price

Overview

The Quote Chart provides detailed and dynamic insights into the Alzchem Group stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Alzchem Group stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Alzchem Group stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Alzchem Group's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Alzchem Group Stock Price History

DateAlzchem Group Price
11/29/202456.60 undefined
11/28/202457.20 undefined
11/27/202457.60 undefined
11/26/202458.80 undefined
11/25/202458.40 undefined
11/22/202459.60 undefined
11/21/202459.80 undefined
11/20/202459.80 undefined
11/19/202460.00 undefined
11/18/202457.60 undefined
11/15/202457.20 undefined
11/14/202458.20 undefined
11/13/202455.20 undefined
11/12/202453.60 undefined
11/11/202453.80 undefined
11/8/202454.20 undefined
11/7/202455.20 undefined
11/6/202455.40 undefined
11/5/202454.60 undefined
11/4/202451.80 undefined
11/1/202451.40 undefined
10/31/202452.20 undefined

Alzchem Group Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Alzchem Group, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Alzchem Group from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Alzchem Group’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Alzchem Group. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Alzchem Group’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Alzchem Group’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Alzchem Group’s growth potential.

Alzchem Group Revenue, EBIT and net profit per share

DateAlzchem Group RevenueAlzchem Group EBITAlzchem Group Net Income
2029e720.29 M undefined59.85 M undefined0 undefined
2028e698.38 M undefined58.37 M undefined0 undefined
2027e675.63 M undefined56.84 M undefined0 undefined
2026e647.83 M undefined89.47 M undefined61.34 M undefined
2025e604.22 M undefined80.36 M undefined54.58 M undefined
2024e573.5 M undefined76.54 M undefined50.47 M undefined
2023540.65 M undefined57.12 M undefined34.62 M undefined
2022542.22 M undefined35.8 M undefined30.05 M undefined
2021422.3 M undefined37.6 M undefined27.6 M undefined
2020379.3 M undefined32.5 M undefined19.7 M undefined
2019376.1 M undefined30.3 M undefined18 M undefined
2018179.98 M undefined10.49 M undefined6.64 M undefined
2017195.24 M undefined23.47 M undefined16.01 M undefined
2016353.9 M undefined33.9 M undefined20.4 M undefined
2015327.2 M undefined32.8 M undefined15.3 M undefined
20140 undefined0 undefined0 undefined
20130 undefined0 undefined0 undefined
20120 undefined0 undefined0 undefined
20110 undefined0 undefined0 undefined
20100 undefined0 undefined0 undefined
20090 undefined0 undefined0 undefined
20080 undefined0 undefined0 undefined
20070 undefined0 undefined0 undefined
200016.3 M undefined-36.5 M undefined-51.1 M undefined
199920.8 M undefined-6.2 M undefined-3.2 M undefined
199812.6 M undefined-900,000 undefined-400,000 undefined

Alzchem Group Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (M)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
199819992000200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e2027e2028e2029e
12201600000000327353195179376379422542540573604647675698720
-66.67-20.00---------7.95-44.76-8.21110.060.8011.3528.44-0.376.115.417.124.333.413.15
8.335.006.25--------64.5363.4661.0358.1060.3763.8561.1450.1857.0453.7550.9947.6045.6344.1342.78
11100000000211224119104227242258272308000000
0-3-510000000015201661819273034505461000
--1,600.00---------33.33-20.00-62.50200.005.5642.1111.1113.3347.068.0012.96---
--------------------------
--------------------------
5.15.15.6000000.10.20.20.210.110.1810.1810.210.210.110.1410.17000000
--------------------------
Details

Keystats

Revenue and Growth

The Alzchem Group Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Alzchem Group is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (k)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (k)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
19992000200720082009201020112012201320142015201620172017201820192020202120222023
                                       
27.92.90.10.10000001818.715.718.712.99.117.18.314.4711.88
10.68.90000000035.43552.335.0434.432.533.140.855.7175.21
00.1000000009.98687.77.16.19.214.7814.14
0.41.40000000064.171.475.571.3878.974.667.486.7122.4107.48
0.20.4000000002.24.454.48.87.38.77.67.277.87
39.113.70.10.1000000129.6137.5154.5137.52142.7130.6132.4152.6214.64216.58
2.42.600000000104.8115.1123.2115.13144.3175.5183.6186.5187.78182.14
011.8000000000000.0300.10.10.10.070.13
200100000000000000000000
5.31.9000000000.8111.010.91.51.82.32.953.66
02.3000000000000000000
5.47.10000000028.626.525.726.525.834.936.436.217.4222.16
13.325.800000000134.2142.6149.9142.66171212221.9225.1208.22208.1
52.439.50.10.1000000263.8280.1304.4280.18313.7342.6354.3377.7422.86424.68
                                       
7.58.80.30.30.30.30.30.30.30.311101.8101.8101.76101.8101.8101.8101.8101.76101.76
39.160.941.541.541.541.541.541.541.541.525252524.982525252524.9824.98
-3.2-54.3-41.8-41.8-41.8-41.8-41.8-41.8-41.8-41.848.4-39.1-23.1-39.08-27.7-18.8-6.81333.5956.52
200000000000-31,000-32,000-31,000-31,993-32,100-48,200-53,100-51,100-15,316-21,639
00000000000000000000
43.615.40000000053.455.772.755.676759.866.988.7145.02161.63
4.16.40000000021.728.230.628.230.924.120.932.837.3931.55
1.25.20000000013.913.11413.1219.718.320.323.421.1325.83
1.24.70000000019.912.618.512.575.24.54.47.75.4814.8
00000000000000000000
0.46.8000000005.622.122.322.1225.413.614.312.368.1210.45
6.923.10000000061.17685.476.0181.260.559.976.2132.1182.63
0.20.3000000002519.416.619.4332.658.554.743.332.1252.04
1.50000000002.32.22.22.172.14.74.74.15.376.29
0.20.700000000122124.7126.2124.69129.3157.5166.4164.5107.32120.16
1.9100000000149.3146.3145146.28164220.7225.8211.9144.81178.49
8.824.100000000210.4222.3230.4222.29245.2281.2285.7288.1276.91261.12
52.439.500000000263.8278303.1277.96312.2341352.6376.8421.93422.74
Details

Balance Sheet

Understanding the Balance Sheet

The balance sheet of Alzchem Group provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Alzchem Group's financial health and stability.

Assets

Alzchem Group's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Alzchem Group must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Alzchem Group after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Alzchem Group's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (k)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
199819992000201320142015201620172017null201820192020202120222023
0-3-51-80212922292292527364148
1130001313713771923242525
0-4-20000000000000
0-4900-14-20-19-20-190-11-11-21-66-20
00170127575110103-419
0000010000011113
00000594943610679
1-10-1200333015301519434843-472
-2-5-600-18-24-15-24-15-24-41-28-28-29-20
-2,000-27,0001,00000-18,000-24,000-15,000-24,000-15,000-24,000-41,000-28,000-28,000-28,000-20,000
0-2170000000000000
0000000000000000
0-1600-410-210-2193-3-1443-38
14500002020000-100
143600-12-5-2-5-27-6-11-2333-49
--1.00--------------
00000-8-170-170-11-9-7-7-10-10
05-50010-20-23-38-802
-1.44-15.88-19.330.14-0.0514.65.78-0.5300-4.952.2519.8814.48-33.3152.11
0000000000000000

Alzchem Group stock margins

The Alzchem Group margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Alzchem Group. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Alzchem Group.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Alzchem Group's sales revenue. A higher gross margin percentage indicates that the Alzchem Group retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Alzchem Group's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Alzchem Group's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Alzchem Group's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Alzchem Group. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Alzchem Group's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Alzchem Group Margin History

Alzchem Group Gross marginAlzchem Group Profit marginAlzchem Group EBIT marginAlzchem Group Profit margin
2029e56.98 %8.31 %0 %
2028e56.98 %8.36 %0 %
2027e56.98 %8.41 %0 %
2026e56.98 %13.81 %9.47 %
2025e56.98 %13.3 %9.03 %
2024e56.98 %13.35 %8.8 %
202356.98 %10.56 %6.4 %
202250.18 %6.6 %5.54 %
202161.31 %8.9 %6.54 %
202063.88 %8.57 %5.19 %
201960.6 %8.06 %4.79 %
201857.82 %5.83 %3.69 %
201760.97 %12.02 %8.2 %
201663.29 %9.58 %5.76 %
201564.52 %10.02 %4.68 %
201456.98 %0 %0 %
201356.98 %0 %0 %
201256.98 %0 %0 %
201156.98 %0 %0 %
201056.98 %0 %0 %
200956.98 %0 %0 %
200856.98 %0 %0 %
200756.98 %0 %0 %
200010.43 %-223.93 %-313.5 %
19998.65 %-29.81 %-15.38 %
199813.49 %-7.14 %-3.17 %

Alzchem Group Stock Sales Revenue, EBIT, Earnings per Share

The Alzchem Group earnings per share therefore indicates how much revenue Alzchem Group has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Alzchem Group earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Alzchem Group's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Alzchem Group’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Alzchem Group's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Alzchem Group Revenue, EBIT and net profit per share

DateAlzchem Group Sales per ShareAlzchem Group EBIT per shareAlzchem Group Earnings per Share
2029e70.78 undefined0 undefined0 undefined
2028e68.63 undefined0 undefined0 undefined
2027e66.39 undefined0 undefined0 undefined
2026e63.66 undefined0 undefined6.03 undefined
2025e59.38 undefined0 undefined5.36 undefined
2024e56.36 undefined0 undefined4.96 undefined
202353.16 undefined5.62 undefined3.4 undefined
202253.5 undefined3.53 undefined2.96 undefined
202141.81 undefined3.72 undefined2.73 undefined
202037.19 undefined3.19 undefined1.93 undefined
201936.87 undefined2.97 undefined1.76 undefined
201817.69 undefined1.03 undefined0.65 undefined
201719.19 undefined2.31 undefined1.57 undefined
201635.04 undefined3.36 undefined2.02 undefined
20151,636 undefined164 undefined76.5 undefined
20140 undefined0 undefined0 undefined
20130 undefined0 undefined0 undefined
20120 undefined0 undefined0 undefined
20110 undefined0 undefined0 undefined
20100 undefined0 undefined0 undefined
20090 undefined0 undefined0 undefined
20080 undefined0 undefined0 undefined
20070 undefined0 undefined0 undefined
20002.91 undefined-6.52 undefined-9.13 undefined
19994.08 undefined-1.22 undefined-0.63 undefined
19982.47 undefined-0.18 undefined-0.08 undefined

Alzchem Group business model

The AlzChem Group AG is a German chemical company headquartered in Trostberg, Bavaria. The company's history dates back to 1868 when chemist Adolph Frank, along with his brother, founded a company for the production of chemical products. Over the following decades, the range and product portfolio were continuously expanded. Today, AlzChem Group AG is one of the leading manufacturers of specialized chemicals and chemical intermediates. The business model of AlzChem Group AG is characterized by a high emphasis on quality and sustainability. The company works with state-of-the-art production facilities and focuses on efficient resource utilization and environmentally friendly production. AlzChem Group AG's customers come from various industries and primarily use the company's products in agriculture, the automotive industry, and the paper and textile industries. In addition to its headquarters in Trostberg, AlzChem Group AG operates additional production sites in Germany, France, and China. Research and development of new products and technologies are important pillars of the business model. For this purpose, AlzChem Group AG also relies on close cooperation with research institutes and universities. AlzChem Group AG is divided into various business segments, each specializing in the production of specialized chemicals and intermediates. One of the most important business segments is agrochemistry, in which AlzChem Group AG produces fertilizers and crop protection agents, for example. The company uses nitrogen compounds that contribute to improved plant growth. Another important business segment is the chemical and paper industry. AlzChem Group AG produces auxiliaries for paper and cardboard production, as well as certain chemicals for the leather and textile industries, among other things. The company is also active in the polymers and plastics industry, producing acrylamides and polyaspartamides, for example. A third business segment of AlzChem Group AG is fine chemistry and the pharmaceutical industry. The company produces special amino acids for medical applications, for example. These are used, for instance, in nutrition and sports medicine. Another pillar of the company is the production of metallurgical specialty products. AlzChem Group AG produces high-purity magnesium products for aluminum production, as well as calcium carbide for the manufacture of welding electrodes, among other things. Overall, AlzChem Group AG offers a wide range of specialized chemicals and intermediates. The company focuses on the highest quality and sustainability in production and research. AlzChem Group AG's customers come from various industries and use the company's products for a wide range of applications. With a strong focus on research and development, AlzChem Group AG meets the challenges of the future and aims for sustainable growth. Alzchem Group is one of the most popular companies on Eulerpool.com.

Alzchem Group SWOT Analysis

Strengths

  • AlzChem Group AG has a strong product portfolio encompassing a wide range of chemicals, including specialty chemicals and fine chemicals.
  • The company has a well-established customer base and long-term relationships with key clients, contributing to a stable revenue stream.
  • AlzChem Group AG has state-of-the-art production facilities and advanced technology, enabling efficient and high-quality manufacturing processes.

Weaknesses

  • The company heavily relies on a few major customers, posing a risk of significant revenue loss if any of these relationships are disrupted.
  • AlzChem Group AG may face challenges in rapidly adapting to changing market dynamics and customer demands due to its relatively rigid organizational structure.
  • The company's limited brand recognition compared to larger competitors may pose a barrier to expanding market share and attracting new customers.

Opportunities

  • Growing demand for environmentally friendly and sustainable chemicals presents an opportunity for AlzChem Group AG to develop and market innovative green products.
  • Expansion into emerging markets, such as Asia and South America, can provide new avenues for business growth and diversification.
  • Strategic partnerships or acquisitions with complementary companies can help AlzChem Group AG enhance its product offerings and expand into new market segments.

Threats

  • Intense competition from both domestic and international chemical companies poses a threat to AlzChem Group AG's market share and profitability.
  • Fluctuating raw material prices, particularly those of key ingredients, can impact the company's production costs and overall financial performance.
  • Increasing regulations and stricter environmental standards in the chemical industry may require significant investments to comply, potentially affecting AlzChem Group AG's profitability.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Alzchem Group Eulerpool Fair Value

Details

Fair Value

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Alzchem Group historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Alzchem Group shares outstanding

The number of shares was Alzchem Group in 2023 — This indicates how many shares 10.17 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Alzchem Group earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Alzchem Group's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Alzchem Group’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Alzchem Group's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Alzchem Group stock splits

In Alzchem Group's history, there have been no stock splits.

Alzchem Group dividend history and estimates

In 2023, Alzchem Group paid a dividend amounting to 1.05 EUR. Dividend means that Alzchem Group distributes a portion of its profits to its owners.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

Dividend Overview

The dividend per year chart for Alzchem Group provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Alzchem Group’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Alzchem Group's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Alzchem Group Dividend History

DateAlzchem Group Dividend
2029e1.2 undefined
2028e1.2 undefined
2027e1.2 undefined
2026e1.2 undefined
2025e1.2 undefined
2024e1.2 undefined
20231.05 undefined
20221 undefined
20210.77 undefined
20200.75 undefined
20190.9 undefined
20181.1 undefined

Alzchem Group dividend payout ratio

In 2023, Alzchem Group had a payout ratio of 33.57%. The payout ratio indicates the percentage of the company's profits that Alzchem Group distributes as dividends.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

What is Yearly Payout Ratio?

The yearly payout ratio for Alzchem Group represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Alzchem Group could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Alzchem Group's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Alzchem Group Payout Ratio History

DateAlzchem Group Payout ratio
2029e32.74 %
2028e32.82 %
2027e32.58 %
2026e32.83 %
2025e33.05 %
2024e31.87 %
202333.57 %
202233.73 %
202128.31 %
202038.66 %
201950.85 %
2018168.61 %
201733.57 %
201633.57 %
201533.57 %
201433.57 %
201333.57 %
201233.57 %
201133.57 %
201033.57 %
200933.57 %
200833.57 %
200733.57 %
200033.57 %
199933.57 %
199833.57 %
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Alzchem Group.

Alzchem Group latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
12/31/20231.13 1.09  (-3.64 %)2023 Q4
9/30/20220.35 0.59  (66.9 %)2022 Q3
3/31/20210.71 0.78  (10.33 %)2021 Q1
12/31/20200.02 0.48  (2,276.24 %)2020 Q4
9/30/20200.32 0.37  (14.48 %)2020 Q3
6/30/20200.65 0.66  (1.3 %)2020 Q2
1

Eulerpool ESG Scorecard© for the Alzchem Group stock

Eulerpool World ESG Rating (EESG©)

55/ 100

🌱 Environment

61

👫 Social

72

🏛️ Governance

31

Environment

Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
110,145
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees10.435
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Alzchem Group shareholders

%
Name
Stocks
Change
Date
22.99222 % Loew (Peter)2,339,757-217,4668/21/2024
15.05005 % Zoellner (Markus)1,531,53808/21/2024
11.61004 % Vorderwuelbecke (Martin)1,181,472-114,9428/21/2024
5.31229 % Lazard Frères Gestion S.A.S.540,59509/30/2024
4.68891 % Janus Henderson Investors477,15809/30/2024
2.73534 % M&G Investment Management Ltd.278,356-300,0006/11/2024
1.10107 % Norges Bank Investment Management (NBIM)112,048112,0486/30/2024
1.09077 % Lupus alpha Asset Management AG111,000111,0006/30/2024
0.74997 % Artisan Partners Limited Partnership76,319-13,2629/30/2024
0.73224 % Universal-Investment-Gesellschaft mbH74,515-12,4857/31/2024
1
2
3
4

Alzchem Group Executives and Management Board

Mr. Andreas Niedermaier

(58)
Alzchem Group Chief Executive Officer, Member of the Management Board
Compensation 818,000

Mr. Klaus Englmaier

(63)
Alzchem Group Chief Operating Officer, Member of the Management Board
Compensation 514,000

Dr. Georg Weichselbaumer

(62)
Alzchem Group Chief Scientific Officer, Member of the Management Board
Compensation 472,000

Mr. Markus Zoellner

(55)
Alzchem Group Chairman of the Supervisory Board (since 2017)
Compensation 42,000

Dr. Caspar Von Schnurbein

(50)
Alzchem Group Deputy Chairman of the Supervisory Board (since 2017)
Compensation 32,000
1
2

Alzchem Group Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
SupplierCustomer0,190,080,23-0,240,330,60
1

Most common questions regarding Alzchem Group

What values and corporate philosophy does Alzchem Group represent?

AlzChem Group AG represents values of innovation, sustainability, and responsibility. With a strong focus on research and development, the company is committed to delivering high-quality products and solutions to its customers. AlzChem Group AG also believes in fostering long-term partnerships and maintaining a customer-centric approach. The company's corporate philosophy emphasizes ethical business practices, environmental stewardship, and the well-being of its employees. By prioritizing these values, AlzChem Group AG aims to create value for its shareholders while contributing to the sustainable progress of society.

In which countries and regions is Alzchem Group primarily present?

AlzChem Group AG is primarily present in Germany, where its headquarters are located. Additionally, the company has a strong presence in other European countries such as Austria, France, and the United Kingdom. With its wide range of chemical products, AlzChem Group AG also operates in international markets, including the United States and China.

What significant milestones has the company Alzchem Group achieved?

AlzChem Group AG, a leading specialty chemicals company, has achieved several significant milestones. Notably, the company successfully completed its IPO in 2017, enabling it to expand its shareholder base and increase financial resources for future growth. AlzChem Group AG has also made noteworthy advancements in its production capabilities and technology, driving innovation and expanding its product portfolio. In addition, the company has achieved numerous certifications and accreditations, demonstrating its commitment to quality and sustainability. Furthermore, AlzChem Group AG has established strategic partnerships with key industry players, fostering collaborations and enhancing its market presence. Such milestones highlight the company's strong growth trajectory and position it as a reputable player in the specialty chemicals industry.

What is the history and background of the company Alzchem Group?

AlzChem Group AG is a leading specialty chemicals company based in Germany. With a rich history dating back over 100 years, AlzChem has grown into a global player in the chemical industry. Initially established as a producer of calcium cyanamide, the company has continuously expanded its portfolio to include a diverse range of products and applications. AlzChem focuses on three main business segments: Specialty Chemicals, Nutrition and Feed, and Performance Materials. By leveraging its expertise and state-of-the-art facilities, AlzChem actively contributes to the development of innovative solutions in various industries, including agriculture, pharmaceuticals, and automotive. With a commitment to sustainability and customer satisfaction, AlzChem Group AG continues to shape the future of chemical manufacturing.

Who are the main competitors of Alzchem Group in the market?

The main competitors of AlzChem Group AG in the market include companies such as BASF SE, Evonik Industries AG, and LANXESS AG. These companies operate in similar industries and offer a range of products that may compete with AlzChem Group AG's offerings. However, AlzChem Group AG has established itself as a leading player in specialty chemicals and innovative chemical products, continually striving to maintain a competitive edge through its strong market position, research and development capabilities, and customer-focused approach.

In which industries is Alzchem Group primarily active?

AlzChem Group AG is primarily active in the chemical industry.

What is the business model of Alzchem Group?

The business model of AlzChem Group AG revolves around specialty chemicals and pharmaceuticals. AlzChem Group AG is a global supplier of various chemical products used in a wide range of industries such as agriculture, nutrition, and fine chemicals. The company focuses on manufacturing, marketing, and developing innovative chemicals that meet the specific needs of its customers. AlzChem Group AG aims to provide high-quality products that contribute to the growth and success of its clients, while also ensuring environmental sustainability and maintaining high safety standards. With its diverse portfolio and commitment to excellence, AlzChem Group AG stands as a leading player in the specialty chemicals industry.

What is the P/E ratio of Alzchem Group 2024?

The Alzchem Group P/E ratio is 11.41.

What is the P/S ratio of Alzchem Group 2024?

The Alzchem Group P/S ratio is 1.

What is the Quality Investing of Alzchem Group?

The Quality Investing for Alzchem Group is 6/10.

What is the revenue of Alzchem Group 2024?

The expected Alzchem Group revenue is 573.5 M EUR.

How high is the profit of Alzchem Group 2024?

The expected Alzchem Group profit is 50.47 M EUR.

What is the business model of Alzchem Group

The AlzChem Group AG is a company located in Trostberg, Bavaria, specializing in the development, production, and marketing of specialty chemicals. The company was founded in 1908 and has been listed on the stock exchange since 2007. The AlzChem Group AG is divided into three divisions: Specialty Chemicals, Basic Chemicals, and Nutrition. Each division has its own products and target markets. The Specialty Chemicals division specializes in the production and marketing of specialty chemicals for applications in agriculture, energy, pharmaceuticals, plastics, and electronics. Examples of products in this division include dicyandiamide, guanidine hydrochloride, and hydrazine hydrate. These chemicals are used in a variety of industrial processes to improve their technical and functional properties. The Basic Chemicals division produces and distributes basic chemicals such as phenol, acetone, melamine, and cyanamide. These chemicals are used by other companies as raw materials in the production of various products. For example, phenol is used in the production of plastics, resins, and paints. Cyanamide is used as a crop protection agent. The Nutrition division specializes in the production of dietary supplements and pharmaceutical active ingredients. The company offers products such as creatine and arginine, which are appreciated by athletes and fitness enthusiasts as dietary supplements. The AlzChem Group AG has an established business model based on the production and marketing of specialty chemicals. The company is able to bring new and innovative products to the market through targeted research and development, as well as investments in modern production technologies. The production capacities are sufficient to produce larger quantities of products. Additionally, high product quality and reliable delivery to customers are guaranteed. The AlzChem Group AG targets customers from various industries, including agriculture, energy, pharmaceuticals, plastics, and electronics. As a publicly traded company, the AlzChem Group AG aims to achieve profitable and stable growth. A smart financial strategy and efficient risk management are therefore important elements of the business model. Networks and partnerships with other companies and research institutions are another important element of the business model and are intended to expand the market potential and explore new business areas. Overall, the AlzChem Group AG is a successful company known for its wide range of products and target markets. The strengths of the company lie in targeted research and development, as well as the high quality of its products and services.

What is the Alzchem Group dividend?

Alzchem Group pays a dividend of 1 EUR distributed over payouts per year.

How often does Alzchem Group pay dividends?

The dividend cannot currently be calculated for Alzchem Group or the company does not pay out a dividend.

What is the Alzchem Group ISIN?

The ISIN of Alzchem Group is DE000A2YNT30.

What is the Alzchem Group WKN?

The WKN of Alzchem Group is A2YNT3.

What is the Alzchem Group ticker?

The ticker of Alzchem Group is ACT.DE.

How much dividend does Alzchem Group pay?

Over the past 12 months, Alzchem Group paid a dividend of 1.05 EUR . This corresponds to a dividend yield of about 1.86 %. For the coming 12 months, Alzchem Group is expected to pay a dividend of 1.2 EUR.

What is the dividend yield of Alzchem Group?

The current dividend yield of Alzchem Group is 1.86 %.

When does Alzchem Group pay dividends?

Alzchem Group pays a quarterly dividend. This is distributed in the months of June, June, June, June.

How secure is the dividend of Alzchem Group?

Alzchem Group paid dividends every year for the past 0 years.

What is the dividend of Alzchem Group?

For the upcoming 12 months, dividends amounting to 1.2 EUR are expected. This corresponds to a dividend yield of 2.09 %.

In which sector is Alzchem Group located?

Alzchem Group is assigned to the 'Commodities' sector.

Wann musste ich die Aktien von Alzchem Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Alzchem Group from 5/10/2024 amounting to 1.2 EUR, you needed to have the stock in your portfolio before the ex-date on 5/8/2024.

When did Alzchem Group pay the last dividend?

The last dividend was paid out on 5/10/2024.

What was the dividend of Alzchem Group in the year 2023?

In the year 2023, Alzchem Group distributed 1 EUR as dividends.

In which currency does Alzchem Group pay out the dividend?

The dividends of Alzchem Group are distributed in EUR.

All fundamentals about Alzchem Group

Our stock analysis for Alzchem Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Alzchem Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.